(Q38977459)

8 September 2017

Comparative nonclinical assessments of the proposed biosimilar PF-05280014 and trastuzumab (Herceptin(®)). (English)

1 reference

8 September 2017

1 reference

6

Gregory L Finch

1 reference

8 September 2017

Susan Hurst

1

1 reference

8 September 2017

Anne M Ryan

2

1 reference

8 September 2017

Chee-Keng Ng

3

1 reference

8 September 2017

James M McNally

4

1 reference

8 September 2017

Leslie G Lorello

5

1 reference

8 September 2017

Michael W Leach

7

1 reference

8 September 2017

Stephen A Ploch

8

1 reference

8 September 2017

Josh A Fohey

9

1 reference

8 September 2017

Teresa A Smolarek

10

1 reference

8 September 2017

1 October 2014

1 reference

8 September 2017

1 reference

8 September 2017

28

1 reference

8 September 2017

5

1 reference

8 September 2017

451-459

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

8 September 2017

start time

8 July 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Analytical lessons learned from selected therapeutic protein drug comparability studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

Immunogenicity of therapeutic proteins: the use of animal models

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

Trastuzumab--mechanism of action and use in clinical practice

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

Predictive power of preclinical studies in animals for the immunogenicity of recombinant therapeutic proteins in humans.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

Mechanism of action of trastuzumab and scientific update

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4176567

The measurement of actin concentration in solution: A comparison of methods

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25001079

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Developing the nation's biosimilars program

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25001079

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The state of the art in the development of biosimilars

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25001079

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40259-014-0103-4

1 reference

8 September 2017

1 reference

8 September 2017

PubMed publication ID

25001079

1 reference